Phenotypic features of innate and adaptive immunity in patients with chronic hepatitis C and end-stage renal disease

被引:6
|
作者
Barbosa, Katia V. B. D. [1 ]
Teixeira, Rosangela [2 ]
Bassetti-Soares, Eric [2 ]
Meirelles de Souza, Aecio F. [1 ]
Penido, Joao Milton M. O. [3 ]
Teixeira-Carvalho, Andrea [4 ]
Martins-Filho, Olindo A. [4 ]
机构
[1] Univ Fed Juiz de Fora, Univ Hosp, Serv Gastroenterol, Juiz De Fora, MG, Brazil
[2] Univ Fed Minas Gerais, Hosp Clin, Inst Alfa Gatroenterol, Dept Clin Med, Belo Horizonte, MG, Brazil
[3] Nucleo Nefrol Belo Horizonte, Belo Horizonte, MG, Brazil
[4] Fundacao Oswaldo Cruz, CPqRR, Belo Horizonte, MG, Brazil
关键词
chronic hepatitis C; end-stage renal disease; flow cytometry; immune response; NATURAL-KILLER-CELLS; CHEMOKINE RECEPTORS; CLINICAL-RELEVANCE; T-CELLS; VIRUS; LIVER; INFECTION; IMMUNOPATHOGENESIS; SUBPOPULATIONS; LYMPHOCYTES;
D O I
10.1111/liv.12204
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The knowledge of the immunological profile of patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) on haemodialysis (HD) is still limited. Aims: This study investigated the immune response profile in HCV patients with concomitant ESRD focusing on the influence of the renal disease on the phenotypic profile of peripheral blood lymphocytes. Methods: Immunophenotypic features of peripheral blood leucocytes were assessed by flow cytometry in two distinct groups: HCV patients with ESRD (CHC+ESRD, n = 16) and HCV patients with normal renal function (CHC, n = 20). Two control groups that were included were as follows: HCV negative blood donors (BD, n = 15) and HCV negative patients with ESRD (ESRD, n = 19). Results: Higher frequency of macrophage-like and pro-inflammatory monocytes along with enhanced frequency of CD3(-)CD16(-)CD56(+), mainly CD56(DIM) NK-cells, were the hallmark of CHC+ESRD patients. Lower frequency of B cells with significant decreased of B1 and CD23(+) B-cells were associated with ESRD, regardless the HCV infection. Although higher rates of activated CD4(+) and CD8(+) T cells were observed in the CHC and CHC+ESRD groups, the chemotaxis of T-cell subsets, based on their chemokine receptor expression, was affected by ESRD. Conclusions: Chronic hepatitis C patients with ESRD on HD exhibit distinctive phenotypic profile of circulating leucocytes. It may be implicated in the natural history of HCV infection in this particular group of patients and warrants further investigation.
引用
收藏
页码:1349 / 1356
页数:8
相关论文
共 50 条
  • [1] IMMUNE RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C AND END-STAGE RENAL DISEASE
    Teixeira, R.
    Barbosa, K. V. B. D.
    Martins Filho, O. A.
    Bassetti-Soares, E.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S326 - S326
  • [2] Management of Chronic Hepatitis C in End-stage Renal Disease
    Angulo-Diaz, Veronica
    Lim, Joseph K.
    Martin, Paul
    Liapakis, AnnMarie
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (04) : 287 - 294
  • [3] Phenotypic features of circulating lymphocytes and its association with crhonic hepatitis C and end-stage renal disease
    Barbosa, K. V. B. D.
    Bassetti-Soares, E.
    Teixeira, R.
    Martins-Filho, O. A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S178 - S178
  • [4] Management of hepatitis C in patients with end-stage renal disease
    Berenguer M.
    Aguilera V.
    Current Hepatitis Reports, 2010, 9 (1) : 38 - 46
  • [5] Hepatitis in patients with end-stage renal disease
    Huang, CC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) : S236 - S241
  • [6] Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
    Aguirre Valadez, Jonathan
    Garcia Juarez, Gnacio
    Rincon Pedrero, Rodolfo
    Torre, Aldo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 329 - 338
  • [7] Hepatitis C virus infection in patients with end-stage renal disease
    Wigneswaran, John
    Van Wyck, David
    Pegues, David
    Gholam, Pierre
    Nissenson, Allen R.
    HEMODIALYSIS INTERNATIONAL, 2018, 22 (03) : 297 - 307
  • [8] Treatment of chronic hepatitis C in patients with end-stage renal disease and hemophilia the Singapore experience
    Chow, WC
    Tien, SL
    Tan, CK
    Lui, HF
    Vathsala, A
    Ng, HS
    INTERVIROLOGY, 2005, 49 (1-2) : 107 - 111
  • [9] Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease
    Pawa, Swati
    Ehrinpreis, Murray
    Mutchnick, Milton
    Janisse, James
    Dhar, Ravi
    Siddiqui, Firdous A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (11) : 1316 - 1320
  • [10] Thrombocytopenia in end-stage renal disease and chronic viral hepatitis B or C
    Orasan, Olga Hilda
    Urian, Laura
    Ciulei, George
    Breaban, Iulia
    Stefan, Andreea Maria
    Secara, Sorina Cezara
    Taut, Adela-Sitar
    Sarlea, Simina Tarmure
    Negrean, Vasile
    Sampelean, Dorel
    Patiu, Ioan Mihai
    Orasan, Remus Aurel
    Cozma, Angela
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (02): : 236 - 243